companyAlkeus Pharmaceuticals, Inc. logo

Senior Clinical Scientist at Alkeus | Cambridge, MA

On-site Full-time $160K/yr - $240K/yr

Clicking Apply Now takes you to AutoApply where you can tailor your resume and apply.


Unlock Your Potential

Generate Job-Optimized Resume

One Click And Our AI Optimizes Your Resume to Match The Job Description.

Is Your Resume Optimized For This Role?

Find Out If You're Highlighting The Right Skills And Fix What's Missing

Experience Level

Senior

Qualifications

Primary Responsibilities:Offer scientific leadership for Phase 3 clinical trials, contributing to the overall clinical development strategy, study design, endpoint selection, and patient population definition with a focus on rare disease and ophthalmology indications. Lead or co-lead the formulation of pivotal study protocols, informed consent forms, and essential scientific sections of regulatory documents, ensuring alignment with global regulatory standards (FDA, EMA, and other health authorities). Act as the scientific point of contact for assigned programs, providing continuous oversight throughout trial execution, including the review of emerging data, risk identification, and result interpretation. Work closely with clinical operations to guarantee that Phase 3 trials are scientifically robust, operationally viable, and executed in accordance with protocols, timelines, and quality standards. Collaborate with biostatistics and data management teams to support statistical analysis plans, data review activities, interim analyses (as applicable), and final interpretation of clinical outcomes. Assist and support regulatory interactions, including preparation for meetings and submission processes.

About the job

Alkeus Pharmaceuticals, Inc. is a pioneering clinical-stage biotechnology firm headquartered in Cambridge, Massachusetts, dedicated to the advancement of groundbreaking therapies aimed at addressing critical ocular diseases with significant unmet medical needs. Established in 2010, Alkeus has been diligently developing its flagship compound, gildeuretinol acetate (ALK-001), which has received designation as a breakthrough therapy and orphan drug status from the U. S. Food and Drug Administration. Gildeuretinol is currently being assessed across various clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) resulting from age-related macular degeneration (AMD), a leading cause of blindness in the United States.

Position Summary:

The Senior Clinical Scientist will take charge of providing scientific leadership and oversight for late-stage (Phase 3) clinical development programs focused on rare diseases in the field of ophthalmology. This role is crucial to maintaining scientific integrity, ensuring regulatory compliance, and successfully executing pivotal clinical trials necessary for global registration.

As a key individual contributor, the Senior Clinical Scientist will act as a primary scientific collaborator throughout the clinical development process, closely partnering with clinical operations, biostatistics, regulatory affairs, and safety teams to translate strategic objectives into high-quality Phase 3 studies. This position is ideally suited for a seasoned professional with a proven track record in late-stage clinical development, particularly in rare diseases and/or ophthalmology.

About Alkeus Pharmaceuticals, Inc.

Alkeus Pharmaceuticals, Inc. is a forward-thinking, clinical-stage biotech company committed to developing transformative therapies for serious eye diseases that currently lack effective treatment options. With a strong focus on innovation and patient care, Alkeus aims to make a significant impact in the field of ophthalmology.

Similar jobs

Tailoring 0 resumes

We'll move completed jobs to Ready to Apply automatically.